scholarly article | Q13442814 |
P819 | ADS bibcode | 2012PLoSO...748610H |
P356 | DOI | 10.1371/JOURNAL.PONE.0048610 |
P8608 | Fatcat ID | release_mxqru76olned7pc77rmy6slpsu |
P932 | PMC publication ID | 3493585 |
P698 | PubMed publication ID | 23144908 |
P5875 | ResearchGate publication ID | 233397036 |
P50 | author | Tomàs Pumarola Suñé | Q41886172 |
Enrique Quintero | Q54231193 | ||
P2093 | author name string | Alvaro Torres | |
Patricia de Molina | |||
Antonio Z Gimeno-García | |||
Manuel Hernández-Guerra | |||
Alejandro Jimenez | |||
Carlos Casanova | |||
Miriam Hernández-Porto | |||
Marta Carrillo | |||
Yanira González-Méndez | |||
P2860 | cites work | The influence of HIV infection on antibody responses to a two-dose regimen of influenza vaccine | Q69741135 |
Immune response to influenza vaccine in adult liver transplant recipients | Q73753116 | ||
Immune response to influenza vaccine in pediatric patients with inflammatory bowel disease | Q80420684 | ||
Cross-reactivity between hepatitis C virus and Influenza A virus determinant-specific cytotoxic T cells | Q27469883 | ||
Peginterferon alfa-2b plus ribavirin compared with interferon alfa-2b plus ribavirin for initial treatment of chronic hepatitis C: a randomised trial | Q27860949 | ||
Type I IFN as a vaccine adjuvant for both systemic and mucosal vaccination against influenza virus | Q28250640 | ||
Influenza vaccination for immunocompromised patients: systematic review and meta-analysis from a public health policy perspective | Q28740919 | ||
Immune response after a single vaccination against 2009 influenza A H1N1 in USA: a preliminary report of two randomised controlled phase 2 trials. | Q30227381 | ||
Willingness of Hong Kong healthcare workers to accept pre-pandemic influenza vaccination at different WHO alert levels: two questionnaire surveys. | Q30380132 | ||
Epidemiology of fatal cases associated with pandemic H1N1 influenza 2009. | Q30380173 | ||
Trial of 2009 influenza A (H1N1) monovalent MF59-adjuvanted vaccine. | Q30380578 | ||
A novel influenza A (H1N1) vaccine in various age groups. | Q30381838 | ||
Seasonal and Pandemic A (H1N1) 2009 influenza vaccination coverage and attitudes among health-care workers in a Spanish University Hospital. | Q30389171 | ||
Acceptance of seasonal and pandemic a (H1N1) 2009 influenza vaccination by healthcare workers in a french teaching hospital | Q30401918 | ||
Neurological and autoimmune disorders after vaccination against pandemic influenza A (H1N1) with a monovalent adjuvanted vaccine: population based cohort study in Stockholm, Sweden | Q30408080 | ||
Immunogenicity and protective efficacy of influenza vaccination | Q35784255 | ||
Development and psychometric validation of a self-administered questionnaire assessing the acceptance of influenza vaccination: the Vaccinees' Perception of Injection (VAPI) questionnaire | Q37139129 | ||
Quantitative analysis of the peripheral blood cytotoxic T lymphocyte response in patients with chronic hepatitis C virus infection | Q37359927 | ||
Incidence of neutropenia and infections during combination treatment of chronic hepatitis C with pegylated interferon alfa-2a or alfa-2b plus ribavirin. | Q38876960 | ||
Use of pegylated interferons is associated with an increased incidence of infections during combination treatment of chronic hepatitis C: a side effect of pegylation? | Q39371548 | ||
Serological response to the 2009 H1N1 influenza vaccination in patients with inflammatory bowel disease | Q42609131 | ||
Impaired serum antibody response to inactivated influenza A and B vaccine in cancer patients | Q42927446 | ||
Immunogenicity and safety of an adjuvanted influenza vaccine in patients with decompensated cirrhosis. | Q43906914 | ||
Rate of infectious complications during interferon-based therapy for hepatitis C is not related to neutropenia | Q43970118 | ||
Identification of chronic hepatitis C patients without hepatic fibrosis by a simple predictive model | Q44151781 | ||
A simple noninvasive index can predict both significant fibrosis and cirrhosis in patients with chronic hepatitis C. | Q44527614 | ||
Development of a simple noninvasive index to predict significant fibrosis in patients with HIV/HCV coinfection | Q44920531 | ||
Risk factors for infection during treatment with peginterferon alfa and ribavirin for chronic hepatitis C. | Q50558699 | ||
Treatment with PEG-interferon and ribavirin for chronic hepatitis C increases neutrophil and monocyte chemotaxis. | Q50561780 | ||
Bacterial infection and neutropenia during peginterferon plus ribavirin combination therapy in patients with chronic hepatitis C with and without baseline neutropenia in clinical practice. | Q50564459 | ||
Neutropenia during combination therapy of interferon alfa and ribavirin for chronic hepatitis C. | Q50583960 | ||
Adjuvant activity of interferon alpha: mechanism(s) of action. | Q50724369 | ||
H1N1 vaccines in a large observational cohort of patients with inflammatory bowel disease treated with immunomodulators and biological therapy. | Q51512458 | ||
Severe influenza infection in a chronic hepatitis C carrier: failure of protective serum HI antibodies after IM vaccination. | Q51638761 | ||
Influenza vaccination in patients with cirrhosis and in liver transplant recipients. | Q51834442 | ||
Type I interferon (IFN alpha) acts directly on human memory CD4+ T cells altering their response to antigen. | Q51891189 | ||
Humoral and cellular immune responses to influenza vaccine in patients with advanced cirrhosis. | Q53606111 | ||
FDA/NIH/WHO public workshop on immune correlates of protection against influenza A viruses in support of pandemic vaccine development, Bethesda, Maryland, US, December 10–11, 2007 | Q54691178 | ||
Strategic Advisory Group of Experts on Immunization - report of the extraordinary meeting on the influenza A (H1N1) 2009 pandemic, 7 July 2009 | Q57110819 | ||
Immunogenicity and safety of influenza vaccination in children with inflammatory bowel disease | Q59563630 | ||
P275 | copyright license | Creative Commons Attribution 4.0 International | Q20007257 |
P6216 | copyright status | copyrighted | Q50423863 |
P433 | issue | 11 | |
P407 | language of work or name | English | Q1860 |
P921 | main subject | chronic hepatitis C | Q55779873 |
P304 | page(s) | e48610 | |
P577 | publication date | 2012-11-08 | |
P1433 | published in | PLOS One | Q564954 |
P1476 | title | Immunogenicity and acceptance of influenza A (H1N1) vaccine in a cohort of chronic hepatitis C patients receiving pegylated-interferon treatment | |
P478 | volume | 7 |
Q93172586 | Effectiveness of influenza vaccines in adults with chronic liver disease: a systematic review and meta-analysis | cites work | P2860 |